We are pioneering a new and innovative precision immunology ecosystem, advancing Precision-First^TM therapeutics for immune-mediated illnesses with creative partnership deals. We collaborate with a range of pharma and biotech players and diagnostics providers, multiple clinical data registries, and other health care stakeholders to help drive meaningful benefits for patients, providers and partners.

We have established clinical collaborations with more than 60 leading global health systems and are leveraging insights from comprehensive data sets across inflammatory bowel disease (IBD), rheumatoid arthritis, sepsis and acute respiratory distress syndrome (ARDS).